CA
TEVA icon

Commerzbank Aktiengesellschaft’s Teva Pharmaceuticals TEVA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-393,552
Closed -$3.53M – 377
2020
Q1 		$3.53M Sell
393,552
-7,502,796
-95% -$76.9M 0.16% 83
2019
Q4 		$77.4M Sell
7,896,348
-786,041
-9% -$7.02M 0.75% 25
2019
Q3 		$59.7M Buy
8,682,389
+3,061,439
+54% +$23.5M 0.46% 49
2019
Q2 		$51.9M Buy
5,620,950
+3,412,966
+155% +$41.2M 0.41% 52
2019
Q1 		$34.6M Buy
2,207,984
+78,636
+4% +$1.39M 0.32% 65
2018
Q4 		$32.8M Sell
2,129,348
-221,570
-9% -$4.54M 0.34% 61
2018
Q3 		$50.6M Sell
2,350,918
-219,659
-9% -$5.1M 0.44% 49
2018
Q2 		$62.5M Sell
2,570,577
-209,928
-8% -$4.28M 0.59% 34
2018
Q1 		$47.5M Sell
2,780,505
-18,687
-0.7% -$365K 0.49% 44
2017
Q4 		$53M Buy
2,799,192
+1,504,349
+116% +$22.6M 0.61% 35
2017
Q3 		$22.8M Buy
1,294,843
+743,401
+135% +$16.7M 0.3% 75
2017
Q2 		$18.3M Sell
551,442
-377,642
-41% -$11.7M 0.31% 77
2017
Q1 		$29.8M Buy
929,084
+731,666
+371% +$25M 0.44% 49
2016
Q4 		$7.16M Buy
197,418
+4,272
+2% +$171K 0.11% 175
2016
Q3 		$8.89M Buy
193,146
+31,502
+19% +$1.64M 0.14% 138
2016
Q2 		$8.12K Sell
161,644
-4,532
-3% -$241K 0.05% 183
2016
Q1 		$8.89M Buy
166,176
+7,324
+5% +$430K 0.07% 154
2015
Q4 		$10.4M Buy
158,852
+12,415
+8% +$767K 0.08% 176
2015
Q3 		$8.27M Buy
146,437
+11,129
+8% +$722K 0.06% 197
2015
Q2 		$8M Buy
135,308
+19,386
+17% +$1.2M 0.04% 254
2015
Q1 		$7.22M Buy
115,922
+25,325
+28% +$1.47M 0.04% 291
2014
Q4 		$5.21M Buy
90,597
+23,796
+36% +$1.33M 0.03% 407
2014
Q3 		$3.59M Buy
66,801
+22,677
+51% +$1.2M 0.01% 585
2014
Q2 		$2.31M Buy
44,124
+15,911
+56% +$813K 0.01% 679
2014
Q1 		$1.49M Sell
28,213
-56,687
-67% -$2.62M 0.01% 765
2013
Q4 		$3.79M Sell
84,900
-90,861
-52% -$3.58M 0.02% 576
2013
Q3 		$6.64M Buy
175,761
+75,273
+75% +$2.94M 0.03% 378
2013
Q2 		$3.94M Buy
+100,488
New +$3.91M 0.02% 602

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TEVA Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 393,552 shares — an estimated $3.53M sold.

Commerzbank Aktiengesellschaft first reported a position in TEVA in Q2 2013 and held it in 28 quarters. The position peaked at $77.4M in Q4 2019. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 393,552 Teva Pharmaceuticals shares in Q2 2020, an estimated $3.53M.
  • Commerzbank Aktiengesellschaft first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Teva Pharmaceuticals position peaked at $77.4M in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.